LIXIANA®▼ (edoxaban) Met Primary Endpoint ...
Hokusai-VTE CANCER study is a phase 3b, prospective, randomised, open-label, blind ...
Since 2004, brands have counted on Cision’s MultiVu to create and distribute their important news and marketing content to the world.
Let's talkSearch our recent client collaborations below: